Pulmonx (Lung) 2025 Earnings Outlook for Investors
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Zero based budgeting yields tangible outcomes compared to traditional budgeting, including tighter control and clearer allocation of resources.
22,247 articlesPulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
As the EV market accelerates, some memory-faded battery names may offer outsized upside. This article dives into how ...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
Finance America’s 2025 profit jumps 175% as originations hit $2.4 billion, reflecting robust demand for home equity l...
Ecopetrol sits at the crossroads of a volatile energy market and a growing emerging markets economy. This deep dive b...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
The first half of 2026 delivered a sharp downturn for Salesforce as AI-driven disruption and market rotation shook th...
As Royal Gold prepares to share Q4 2025 results, investors should focus on streaming contracts, cash flow, and balanc...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...